Skip to main content
Sino Medical Sciences Technology Inc. logo

Sino Medical Sciences Technology Inc. — Investor Relations & Filings

Ticker · 688108 ISIN · CNE100003NY2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2025-10-30 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 688108

About Sino Medical Sciences Technology Inc.

https://www.sinomed.com/

Sino Medical Sciences Technology Inc. (SINOMED) specializes in the research, development, and manufacturing of high-end interventional medical devices. The company focuses on cardiovascular, neurovascular, and structural heart disease treatments. Its core product portfolio includes drug-eluting stents (DES) and balloon catheters, notably the BuMA and BuMA Supreme series. SINOMED utilizes proprietary technologies, such as the eG™ coating, to improve clinical outcomes and patient safety. The company maintains a strong commitment to clinical research and international expansion, aiming to provide innovative solutions for minimally invasive procedures.

Recent filings

Filing Released Lang Actions
赛诺医疗科学技术股份有限公司2025年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2025 Third Quarter Report" of 赛诺医疗科学技术股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2025. The report explicitly states it is unaudited and covers the period from the start of the quarter to the end of the quarter (3 months). The length of the document (over 13,000 characters) and the presence of substantive financial data confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2025
2025-10-30 Chinese
赛诺医疗科学技术股份有限公司关于召开子公司产品注册申请未获批准的投资者交流会通知公告
Investor Presentation Classification · 90% confidence The document is a notice announcing an upcoming investor communication meeting regarding a subsidiary's product registration application that was not approved by the national drug regulatory authority. It details the meeting time, location, participants, and how investors can participate and ask questions. The document does not contain financial statements, earnings data, or detailed report content. It is an announcement of an investor meeting rather than the meeting materials or transcript itself. Therefore, it fits best as an Investor Presentation (IP) type, since it is a detailed presentation for investors focusing on company developments and strategy, specifically addressing regulatory and operational issues.
2025-10-28 Chinese
赛诺医疗科学技术股份有限公司关于子公司产品注册申请未获国家药监局批准的自愿性披露公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement by the company regarding the non-approval of a product registration application by the National Medical Products Administration (国家药监局). It details the regulatory status of a medical device product domestically and internationally, the company's plans, and risk disclosures. The document is an official announcement about regulatory approval status and company plans, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. It is a regulatory announcement about product registration and regulatory matters, fitting best under Regulatory Filings (RNS). The document length is short (1829 characters), and it is not a report publication announcement or certification letter. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-10-28 Chinese
赛诺医疗科学技术股份有限公司关于股东解除一致行动关系的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the termination of a shareholder agreement of acting in concert among certain shareholders and the actual control status of the company. It details changes in shareholder relationships but explicitly states that there is no change in actual control or shareholding percentages. There are no financial statements, earnings data, or detailed financial analysis. The document is a formal disclosure about shareholder relations and control, typical of a Major Shareholding Notification or related shareholder structure update. However, since it does not report a change in shareholding thresholds but rather the ending of a concert party relationship, it fits best under Major Shareholding Notification (MRQ) as it concerns significant shareholder relationship disclosures affecting control. The document length is 3262 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the classification is MRQ with high confidence.
2025-10-17 Chinese
赛诺医疗科学技术股份有限公司简式权益变动报告书（孙箭华）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding of an individual shareholder, Sun Jianhua, including the reduction of controlled shares due to the termination of a concerted action agreement. The document includes detailed information about the shareholder, the nature of the shareholding change, the number of shares before and after the change, and legal declarations. It is a formal disclosure of a change in major shareholding, consistent with regulatory requirements under Chinese securities law. There is no indication that this is an annual report, earnings release, or any other type of report. The content matches the definition of a Major Shareholding Notification, which involves notification of changes in significant share ownership levels crossing thresholds.
2025-10-17 Chinese
赛诺医疗科学技术股份有限公司关于股东权益变动的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a change in shareholder equity due to the termination of a concerted action agreement among shareholders. It details the reduction in control percentage of the actual controller, Mr. Sun Jianhua, but explicitly states that there is no change in the controlling shareholder or actual controller. The document includes specific shareholding numbers before and after the change and mentions a related simplified equity change report filed on the Shanghai Stock Exchange website. The content focuses on notifying the market about a change in major shareholding and related disclosures, without financial statements or management discussion. The document length is short (1767 characters), and it is a formal announcement of a shareholding change rather than a full report or financial filing. Therefore, it fits the category of Major Shareholding Notification (MRQ).
2025-10-17 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.